| 1 |
Capsules |
Silodosin 8mg & Dutasteride 0.5mg Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Silodosin |
|
8 mg |
| Dutasteride (as uncoated tablet) |
I.P. |
0.5 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 2 |
Capsules |
Diacerein Capsules 50mg I.P |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Diacerein |
I.P. |
50 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 3 |
Capsules |
Calcium Dobesilate Capsules 500 mg. |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Calcium Dobesilate Monohydrate |
I.P. |
500 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 4 |
Capsules |
Alpha Lipoic Acid, Methylcobalamin, Pyridoxine Hydrochloride, Folic Acid, Benfotiamine, Chromium Picolinate & Biotin Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Alpha Lipoic Acid |
USP |
100 mg |
| Methylcobalamin |
I.P. |
1500 mcg |
| Pyridoxine Hydrochloride |
I.P. |
3 mg |
| Folic Acid |
I.P. |
1.5 mg |
| Benfotiamine |
I.P. |
50 mg |
| Chromium Picolinate eq. to Chromium |
USP |
200 mcg |
| Biotin |
USP |
5 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 5 |
Capsules |
Itraconazole Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Itraconazole (as pellets) |
I.P. |
100 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells & pellets |
|
|
|
| 6 |
Capsules |
Aspirin Gasto-resistant & Rosuvastatin Capsules I.P |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Aspirin (as enteric coated pellets) |
I.P. |
75 mg |
| Rosuvastatin Calcium eq. to Rosuvastatin (as pellets) |
I.P. |
20 mg |
| Excipients |
|
q.s. |
| Approved Colour used in empty capsule shells & pellets |
|
|
|
| 7 |
Capsules |
Itraconazole Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Itraconazole (as pellets) |
I.P. |
200 mg |
| Excipients |
|
q.s. |
| Approved Colour used in empty capsule shells |
|
|
|
| 8 |
Capsules |
Mefenamic Acid Capsules I.P 250 mg |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Mefenamic Acid |
I.P. |
250 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 9 |
Capsules |
Thiocolchicoside Capsules I.P 8 mg |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Thiocolchicoside |
I.P. |
8 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 10 |
Capsules |
Thiocolchicoside Capsules I.P 4 mg |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Thiocolchicoside |
I.P. |
4 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 11 |
Capsules |
Clindamycin Hydrochloride Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Clindamycin Hydrochloride eq. to Clindamycin |
I.P. |
300 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 12 |
Capsules |
Rosuvastatin and Aspirin Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Rosuvastatin Calcium eq. to Rosuvastatin (as pellets) |
I.P. |
10 mg |
| Aspirin (as enteric coated pellets) |
I.P. |
75 mg |
| Excipients |
|
q.s. |
| Approved colour used |
|
|
|
| 13 |
Capsules |
Rosuvastatin and Aspirin Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Rosuvastatin Calcium eq. to Rosuvastatin (as granules) |
I.P. |
20 mg |
| Aspirin (as enteric coated tablets) |
I.P. |
75 mg |
| Excipients |
|
q.s. |
| Approved colour used |
|
|
|
| 14 |
Capsules |
Rosuvastatin and Aspirin Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Rosuvastatin Calcium eq. to Rosuvastatin (as granules) |
I.P. |
10 mg |
| Aspirin (as enteric coated tablets) |
I.P. |
75 mg |
| Excipients |
|
q.s. |
| Approved colour used |
|
|
|
| 15 |
Capsules |
Doxycycline & Lactic Acid Bacillus Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Doxycycline Hydrochloride eq. to Doxycycline |
I.P. |
100 mg |
| Lactic Acid Bacillus |
|
60 Million Spores |
| Excipients |
|
q.s. |
| Approved colour used in capsule shells |
|
|
|
| 16 |
Capsules |
Rosuvastatin, Clopidogrel and Aspirin Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Rosuvastatin Calcium eq. to Rosuvastatin (as pellets) |
I.P. |
10 mg |
| Clopidogrel Bisulphate eq. to Clopidogrel (as pellets) |
I.P. |
75 mg |
| Aspirin (as enteric coated pellets) |
I.P. |
75 mg |
| Excipients |
|
q.s. |
| Approved colour used |
|
|
|
| 17 |
Capsules |
Rabeprazole Sodium(EC) and Aceclofenac (SR) Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Rabeprazole Sodium (as enteric coated pellets) |
I.P. |
20 mg |
| Aceclofenac (as sustained release pellets) |
I.P. |
200 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 18 |
Capsules |
Esomeprazole (EC) and Itopride HCl (SR) Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Esomeprazole Magnesium Trihydrate eq. to Esomeprazole (as enteric coated pellets) |
I.P. |
40 mg |
| Itopride Hydrochloride (as sustained released pellets) |
I.P. |
150 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 19 |
Capsules |
Omeprazole Gastro-resistant Capsules I.P. |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Omeprazole (as gastro resistant pellets) |
I.P. |
20 mg |
| Excipients |
|
q.s. |
| Approved colour used in capsule shells |
|
|
|
| 20 |
Capsules |
Methylcobalamin, Alpha Lipoic Acid, Benfotiamine, Pyridoxine HCl, Inositol and Folic Acid Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Methylcobalamin |
I.P. |
1000 mcg |
| Alpha Lipoic Acid |
I.P. |
200 mg |
| Benfotiamine |
|
100 mg |
| Folic Acid |
I.P. |
1.5 mg |
| Pyridoxine HCl |
I.P. |
3 mg |
| Inositol |
USP |
100 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 21 |
Capsules |
Methylcobalamin, Alpha Lipoic Acid, Benfotiamine, Pyridoxine HCl, Inositol and Folic Acid Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Methylcobalamin |
I.P. |
1000 mcg |
| Alpha Lipoic Acid |
I.P. |
200 mg |
| Benfotiamine |
|
100 mg |
| Folic Acid |
I.P. |
1.5 mg |
| Pyridoxine HCl |
I.P. |
3 mg |
| Inositol |
USP |
100 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 22 |
Capsules |
Methylcobalamin, Alpha Lipoic Acid, Thiamine Mononitrate, Pyridoxine Hydrochloride, and Folic Acid Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Methylcobalamin |
I.P. |
1500 mcg |
| Alpha Lipoic Acid |
I.P. |
100 mg |
| Thiamine Mononitrate |
I.P. |
10 mg |
| Pyridoxine Hydrochloride |
I.P. |
3 mg |
| Folic Acid |
I.P. |
1.5 mg |
| Excipients |
|
q.s. |
| Appropriate overages of vitamins are added to compensate loss on storage |
|
|
| Approved colour used in empty capsule shells |
|
|
|
| 23 |
Capsules |
Pregabalin and Methylcobalamin Capsules I.P |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Pregabalin |
I.P. |
75 mg |
| Methylcobalamin |
I.P. |
750 mcg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
| Appropriate overages of vitamin added to compensate loss on storage |
|
|
|
| 24 |
Capsules |
Esomeprazole and Levosulpride Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Esomeprazole Magnesium Trihydrate eq. to Esomeprazole (as enteric coated pellets) |
I.P. |
40 mg |
| Levosulpiride (as sustained released pellets) |
|
75 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 25 |
Capsules |
Pantoprazole and Levosulpiride Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Pantoprazole Sodium eq. to Pantoprazole (as enteric coated pellets) |
I.P. |
40 |
| Levosulpiride (as sustained released pellets) |
|
75 |
| Excipients |
|
|
| Approved colour used in empty capsule shells |
|
|
|
| 26 |
Capsules |
Rebeprazole and Itopride Hydrochloride Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Rabeprazole Sodium (as enteric coated pellets) |
I.P. |
20 mg |
| Itopride Hydrochloride (as sustained released pellets) |
|
150 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 27 |
Capsules |
Esomeprazole and Domperidone Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Esomeprazole Magnesium Trihydrate eq. to Esomeprazole (as enteric coated pellets) |
I.P. |
40 mg |
| Domperidone (as sustained released pellets) |
I.P. |
30 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 28 |
Capsules |
Rabeprazole and Levosulpride Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Rabeprazole Sodium (as enteric coated pellets) |
I.P. |
20 mg |
| Levosulpiride (as sustained released pellets) |
|
75 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 29 |
Capsules |
Pantoprazole Gasto-resistant and Domperidone Prolonged-release Capsules I.P |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Pantoprazole Sodium eq. to Pantoprazole (as gastro-resistant pellets) |
I.P. |
40 mg |
| Domperidone (as prolonged-release pellets) |
I.P. |
30 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 30 |
Capsules |
Rabeprazole and Domperidone Capsule |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Rabeprazole Sodium (as enteric coated pellets) |
I.P. |
20 mg |
| Domperidone (as sustained released pellets) |
I.P. |
30 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 31 |
Capsules |
Omeprazole and Domperidone Capsules I.P |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Omeprazole (as enteric coated pellets) |
I.P. |
20 mg |
| Domperidone |
I.P. |
10 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 32 |
Capsules |
Methylcobalamin, Alpha Lipoic Acid, Inositol, Folic Acid, Chromium Polynicotinate, Selenium Dioxide and Benfotiamine Capsules |
| Composition |
Standard |
Quantity |
| Each hard gelatin capsule contains : |
|
|
| Methylcobalamin |
I.P. |
1500 mcg |
| Alpha Lipoic Acid |
USP |
100 mg |
| Inositol |
USP |
100 mg |
| Folic Acid |
I.P. |
1.5 mg |
| Chromium Polynicotinate |
USP |
200 mcg |
| Selenium Dioxide |
B.P. |
55 mcg |
| Benfotiamine |
USP |
150 mg |
| Excipients |
|
q.s. |
| Approved colour used in empty capsule shells |
|
|
|
| 33 |
Capsules |
Methylcobalamin, Alpha Lipoic Acid, Inositol, Folic Acid, Chromium Polynicotinate, Selenium Dioxide and Benfotiamine Capsules |
| Ingredient |
Standard |
Quantity |
| Methylcobalamin |
I.P |
1500 mcg |
| Alpha Lipoic Acid |
USP |
100 mg |
| Inositol |
USP |
100 mg |
| Folic Acid |
I.P |
1.5 mg |
| Chromium Polynicotinate |
USP |
200 mcg |
| Selenium Dioxide |
B.P |
55 mcg |
| Benfotiamine |
USP |
150 mg |
| Excipients |
— |
q.s. |
| Approved colour used in empty capsule shells |
— |
— |
|
